| GOLDENWELL BIOTECH, INC. (GWLL) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | ||||||||||||||||||||||||||
| Fiscal Period | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | ||||||||||||||||||||||||||
| Operating Cash Flow | (13,361$) | (18,848$) | (30,885$) | 59,380$ | (32,276$) | (25,351$) | (20,965$) | (47,751$) | (29,010$) | (19,076$) | (35,210$) | (26,946$) | (31,921$) | (917,090$) | 15,222$ | (25,037$) | (145,655$) | (19,373$) | (12,506$) | (150,201$) | (150,200$) | (2,975$) | (142$) | (2,329$) | (2,311$) | ||||||||||||||||||||||||
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 0$ | 0$ | 0$ | 0$ | 0$ | 70,000$ | 0$ | 49,250$ | 0$ | 60,388$ | 30,000$ | 0$ | 30,000$ | 0$ | 0$ | 170,125$ | 170,125$ | 170,125$ | 1,000$ | 0$ | 7,300$ | 248,904$ | |||||||||||||||||||||||||||
| End Cash Position | 13,414$ | 26,775$ | 45,622$ | 76,507$ | 17,127$ | 49,404$ | 4,755$ | 25,720$ | 24,221$ | 53,231$ | 11,920$ | 17,130$ | 44,075$ | 45,996$ | 58,086$ | 42,864$ | 67,901$ | 213,556$ | 232,929$ | 245,435$ | 248,569$ | 248,569$ | 250,544$ | 251,422$ | 251,564$ | 246,593$ | 0$ | ||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (13,361$) | (18,848$) | (30,885$) | 59,380$ | (32,276$) | (25,351$) | (20,965$) | (47,751$) | (29,010$) | (19,076$) | (35,210$) | (26,946$) | (31,921$) | (917,090$) | 15,222$ | (25,037$) | (145,655$) | (19,373$) | (12,506$) | (150,201$) | (150,200$) | (2,975$) | (142$) | (2,329$) | (2,311$) | ||||||||||||||||||||||||